SEC Form 4 · accession 0001127602-18-020725
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dan Goldstein
Officer — VP, Corporate Controller
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 8, 2018 | S | 578 | $92.90 | D | 3,022 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2018.
- F2This number includes unvested restricted stock units previously reported.